{"database": "openregs", "table": "congressional_record", "rows": [["CREC-2020-12-31-pt1-PgH9170", "2020-12-31", 116, 2, null, null, "EXPANDING FINDINGS FOR FEDERAL OPIOID RESEARCH AND TREATMENT ACT", "HOUSE", "HOUSE", "ALLOTHER", "H9170", "H9170", "[{\"name\": \"Debbie Dingell\", \"role\": \"speaking\"}]", "[{\"congress\": \"116\", \"type\": \"HR\", \"number\": \"3153\"}, {\"congress\": \"116\", \"type\": \"HR\", \"number\": \"3153\"}]", "166 Cong. Rec. H9170", "Congressional Record, Volume 166 Issue 223 (Thursday, December 31, 2020)\n\n[Congressional Record Volume 166, Number 223 (Thursday, December 31, 2020)]\n[House]\n[Page H9170]\nFrom the Congressional Record Online through the Government Publishing Office [www.gpo.gov]\n\n    EXPANDING FINDINGS FOR FEDERAL OPIOID RESEARCH AND TREATMENT ACT\n\n  Mrs. DINGELL. Madam Speaker, I ask unanimous consent to take from the\nSpeaker's table the bill (H.R. 3153) to direct the Director of the\nNational Science Foundation to support research on opioid addiction,\nand for other purposes, with the Senate amendment thereto, and concur\nin the Senate amendment.\n  The Clerk read the title of the bill.\n  The SPEAKER. The Clerk will report the Senate amendment.\n  The Clerk read as follows:\n  Senate amendment:\n\n        Strike all after the enacting clause and insert the\n     following:\n\n     SECTION 1. SHORT TITLE; FINDINGS.\n\n       (a) Short Title.--This Act may be cited as the ``Expanding\n     Findings for Federal Opioid Research and Treatment Act'' or\n     the ``EFFORT Act''.\n       (b) Findings.--The Congress finds that--\n       (1) research gaps currently exist in the prevention and\n     treatment of opioid addiction;\n       (2) the National Science Foundation's research on opioid\n     addiction has increased understanding of the neuroscience of\n     addiction, substance abuse intervention, the role of illicit\n     supply networks, the secondary effects on families, the use\n     of technology to address the opioid epidemic, and options for\n     alternative, non-addictive therapeutics for pain; and\n       (3) the National Science Foundation and the National\n     Institutes of Health have recognized that fundamental\n     questions in basic, clinical, and translational research\n     would benefit greatly from multidisciplinary approaches and\n     collaboration.\n\n     SEC. 2. NSF SUPPORT OF RESEARCH ON OPIOID ADDICTION.\n\n       The Director of the National Science Foundation, in\n     consultation with the Director of the National Institutes of\n     Health, shall support merit-reviewed and competitively\n     awarded research on the science of opioid addiction.\n\n  Mrs. DINGELL (during the reading). Madam Speaker, I ask unanimous\nconsent to dispense with the reading.\n  The SPEAKER. Is there objection to the request of the gentlewoman\nfrom Michigan?\n  There was no objection.\n  The SPEAKER. Is there objection to the original request of the\ngentlewoman from Michigan?\n  There was no objection.\n  A motion to reconsider was laid on the table.\n\n                          ____________________"]], "columns": ["granule_id", "date", "congress", "session", "volume", "issue", "title", "chamber", "granule_class", "sub_granule_class", "page_start", "page_end", "speakers", "bills", "citation", "full_text"], "primary_keys": ["granule_id"], "primary_key_values": ["CREC-2020-12-31-pt1-PgH9170"], "units": {}, "query_ms": 4.408877808600664, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}